SCHEMBL30666279

SCHEMBL30666279

Cc1c(N2CC3(CN(C(=O)OC(C)(C)C)C3)C2)sc2nnc(Cl)cc12

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ OXTR P30559 1/20 0.37
▸ AVPR1A P37288 1/20 0.37
▸ EGLN2 Q96KS0 1/20 0.36
▸ CYP11B2 P19099 1/20 0.35
▸ ACACB O00763 6/20 0.35
▸ KRAS P01116 1/20 0.35
▸ GPR119 Q8TDV5 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ SCD5 Q86SK9 1/20 0.34
▸ EIF2AK4 Q9P2K8 1/20 0.34
▸ MKNK1 Q9BUB5 3/20 0.33
▸ RET P07949 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ EHMT2 Q96KQ7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26683497 1.00 OXTR (0.37) OXTRAVPR1AEGLN2CYP11B2ACACB
SCHEMBL26683384 0.86 OXTR (0.39) OXTRAVPR1AEGLN2CYP11B2GPR119
SCHEMBL30666275 0.86 OXTR (0.39) OXTRAVPR1AEGLN2CYP11B2GPR119
SCHEMBL30666283 0.82 SMARCA2 (0.50) OXTRAVPR1AEGLN2CYP11B2KRAS
SCHEMBL26683378 0.82 SMARCA2 (0.50) OXTRAVPR1AEGLN2CYP11B2KRAS
SCHEMBL30666241 0.76 OXTR (0.39) OXTRAVPR1AEGLN2CYP11B2ACACB
SCHEMBL26683395 0.76 OXTR (0.39) OXTRAVPR1AEGLN2CYP11B2ACACB
SCHEMBL26683610 0.75 OXTR (0.43) OXTRAVPR1AEGLN2CYP11B2ACACB
SCHEMBL30666269 0.75 OXTR (0.42) OXTRAVPR1ACYP11B2ACACBKRAS
SCHEMBL26683430 0.75 OXTR (0.42) OXTRAVPR1ACYP11B2ACACBKRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522277-A1 PYRAZINE DERIVATIVES AND USES THEREOF Foghorn Therapeutics Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220137-A1 PYRAZINE DERIVATIVES AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2023-11-16 — — WO disclosed
Send feedback